Home Stock

Stock Research: Coloplast

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Coloplast

CPH:COLO B DK0060448595
15
  • Value
    42
  • Growth
    29
  • Safety
    Safety
    34
  • Combined
    15
  • Sentiment
    49
  • 360° View
    360° View
    15
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Coloplast A/S is a healthcare company that develops, markets, and sells intimate healthcare products and services. It operates in the healthcare sector with a focus on Ostomy Care, Continence Care, Urology Care, and Wound & Skin Care. The company supplies products to hospitals, institutions, wholesalers, and pharmacies and operates in Denmark. In the last fiscal year, the company had a market cap of $21,405 million, profits of $2,729 million, and revenue of $4,038 million and 16,247 employees.

more

ANALYSIS: With an Obermatt 360° View of 15 (better than 15% compared with alternatives), overall professional sentiment and financial characteristics for the stock Coloplast are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Coloplast. The consolidated Value Rank has a low rank of 42 which means that the share price of Coloplast is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 58% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 29, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 29% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 34, which means that the company has a riskier financing structure than 66% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 49, which means that professional investors are more pessimistic about the stock than for 51% of alternative investment opportunities. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Market Pulse
Country Denmark
Industry Health Care Supplies
Size X-Large
Website coloplast.dk
Index
OMX C20
Renewables Users
Coloplast stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
42 22 17 21
Growth
29 72 57 29
Safety
Safety
34 10 8 68
Sentiment
49 46 49 30
360° View
360° View
15 15 8 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
7 15 28 31
Opinions Change
50 50 39 34
Pro Holdings
n/a 80 42 45
Market Pulse
98 47 78 54
Sentiment
49 46 49 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
42 22 17 21
Growth
29 72 57 29
Safety Safety
34 10 8 68
Combined
15 12 4 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
32 7 6 7
Price vs. Earnings (P/E)
28 19 17 8
Price vs. Book (P/B)
11 3 1 3
Dividend Yield
91 86 78 82
Value
42 22 17 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
45 71 65 58
Profit Growth
72 34 61 14
Capital Growth
51 86 36 36
Stock Returns
12 44 47 55
Growth
29 72 57 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
9 5 14 58
Refinancing
63 1 5 13
Liquidity
64 65 52 96
Safety Safety
34 10 8 68

Similar Stocks

Discover high‑ranked alternatives to Coloplast and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Alcon

VTX:ALC
Country: Switzerland
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: XX-Large
Full Stock Analysis

Michelin

PAR:ML
Country: France
Industry: Tires & Rubber
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews